Rechercher des projets européens

Plus de 40 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 

Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine (MEL-PLEX)

Date du début: 1 déc. 2014, Date de fin: 30 nov. 2018,

Novel treatment options and associated personalised, patient-tailored therapies need to be explored and developed for highly heterogeneous and chemotherapy resistant cancers, such as malignant melanoma. This can only be achieved by industry-academia collaborations in newly emerging, innovative research disciplines such as translational cancer systems biology and systems medicine. These disciplines ...
Voir le projet

 11

 TERMINÉ 

Co-funding of International Fellowships in Cancer Research (FELCARES)

Date du début: 1 avr. 2010, Date de fin: 31 mars 2014,

"The Italian Association for Cancer Research (AIRC), the Italian leading charity providing about 40% of all research funds invested in cancer research in Italy, proposes to award 60 fellowship-years for international mobility in two yearly calls for proposals. The calls will be published, executed, and concluded in the 4 years of the FELCARES duration. AIRC aims at increasing its international dim ...
Voir le projet

 1

 TERMINÉ 

Excellent research and expertise of quality of cancer care by internationally trained staff (INEXCA)

Date du début: 1 mars 2015, Date de fin: 28 févr. 2019,

...international imperative to improve healthcare through health service research, including nursing research and new innovations. This EU-RISE project “Excellent research and expertise of quality of cancer care by internationally trained staff (INEXCA)” aims to utilize expertise across the globe to improve research, researcher training and care of cancer patients, family caregivers and patient and ...
Voir le projet

 7

 TERMINÉ 

Synthesis of molecular probes for cancer research based on priviliged natural products through a novel enantioselective oxidative arylation technology (Pyrroloindole)

Date du début: 1 sept. 2012, Date de fin: 31 août 2014,

...the molecular structures and synthetic targets have been selected in close collaboration with the group of Dr. Murrell at CRUK Cambridge. This collaboration is aimed at understanding the processes of cancer generation and growth at the molecular level through development of small molecule histone methylation and acetylation modulators. To study such processes a priviliged and synthetically challen ...
Voir le projet

 1

 TERMINÉ 

"ECNIS2: towards ECNIS Centre for Research and Education on Cancer, Environment and Food" (ECNIS2)

Date du début: 1 juin 2011, Date de fin: 31 mai 2013,

...continuing the integrative and coordinative works initiated during ECNIS network with an ultimate goal of transforming network into a virtual centre, the European Centre for Research and Education on Cancer, Environment and Food (ECRECEF).ECNIS has already laid foundations for the development of the centre by bringing together researchers from different disciplines (epidemiology, chemical analysis ...
Voir le projet

 23

 TERMINÉ 

Crossborder Applied Biotech: New perspectives in cancer and regenerative medical research by integration of cross-border resources (CABCOS II)

Date du début: 14 juin 2013, Date de fin: 13 oct. 2014,

...he basis for keeping the highly-educated work force in the region, as well as for attracting new researchers from other areas. The research infrastructure will enable basic research in such fields as cancer research and regenerative medicine, but it will also be an opportunity for closer cooperation with the biotechnological and pharmaceutical industry in the region. ...
Voir le projet

 2

 TERMINÉ 

Driving Excellence in Integrative Cancer Research through Innovative Biomedical Infrastructures (INTEGRATE)

Date du début: 1 févr. 2011, Date de fin: 31 oct. 2014,

There is a strong need in biomedical research, especially in the case of complex heterogeneous diseases such as cancer, to achieve an all-comprising harmonization of efforts: To integrate the available data and knowledge in comprehensive models supported by interoperable infrastructures and tools, to standardize methodologies, and to achieve wide-scale data sharing and reuse, and multidisciplinary ...
Voir le projet

 7

 TERMINÉ 

ERA-NET on Translational Cancer Research (TRANSCAN)

Date du début: 1 janv. 2011, Date de fin: 31 déc. 2014,

"Cancer is a worldwide health burden and a major public health challenge in Europe, responsible for 25% of all deaths; a situation expected to worsen with population ageing. The strengthening of translational cancer research is an urgent need in European cancer research, i.e. the integration of basic, epidemiological, preclinical and clinical research with the implementation and evaluation of inte ...
Voir le projet

 29

 TERMINÉ 

EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS (ENCCA)

Date du début: 1 janv. 2011, Date de fin: 31 déc. 2015,

"ENCCA aims to establish a durable, European Virtual Institute clinical and translational research in childhood and adolescent cancers that will define and implement an integrated research strategy and will facilitate the necessary investigator-driven clinical trials to introduce the new generation of biologically targeted drugs into standard of care for children and adolescents with cancer. This ...
Voir le projet

 34

 TERMINÉ 

Specialized cantilevers for cancer research (SCANCER)

Date du début: 1 mars 2010, Date de fin: 19 mai 2014,

"Research in the mechanical properties of cells will help to develop novel techniques and methods to complement traditional methods of cancer detection and means to evaluate the efficiency of cancer drugs. The objective of this project is to achieve significant advances in such field using specific cantilevers with customized geometries, added functionalities and engineered tips. More concretely, ...
Voir le projet

 1

 TERMINÉ 

Translational Research Network in Prostate Cancer (TransPot)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,

The Translational Research Network for Prostate Cancer (TransPot) program adopts an innovative, multidisciplinary approach, providing highly sought-after, effective solutions for incurable prostate cancer (PC).The TransPot scientific objective is to obtain an unmatched depth of molecular, mechanistic and informatics systems-level disease understanding in order to improve the prognosis and treatmen ...
Voir le projet

 11

 TERMINÉ 

International Cancer Research Fellowships (ICARE)

Date du début: 1 avr. 2014, Date de fin: 31 mars 2018,

The Italian Association for Cancer Research (AIRC), the Italian leading charity providing about 40% of all research funds invested in cancer research in Italy, proposes to award 56 fellowship/years for international mobility in two yearly calls for proposals. The fellowships will be awarded, started and concluded in the 4 years of the iCARE duration.iCARE will address the following issues:- Intern ...
Voir le projet

 1

 TERMINÉ 

A European Platform for Translational Cancer Research (EUROCANPLATFORM)

Date du début: 1 janv. 2011, Date de fin: 31 déc. 2016,

Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the increasing burden posed by cancer. The FP6 Eurocan+Plus project analysed the barriers underlying the increasing fragmentation of cancer research and stressed the need to improve collaboration between basic/preclinical and comprehensive cancer centres (CCCs), in ...
Voir le projet

 29

 TERMINÉ 

INtegrating the emerging research Potential of the University of Athens Cancer Research Group in the European research area (INsPiRE)

Date du début: 1 sept. 2011, Date de fin: 31 août 2014,

The main concept of INsPiRE is the scientific and technological reinforcement of the National & Kapodistrian University of Athens (NKUA) basic and translational Cancer Research Group (NKUA-CRG) towards its integration into the more advanced core of the European cancer research area. Thus, a central objective of the proposal is to gain a full convergence of NKUA-CRG to the European research area of ...
Voir le projet

 1

 TERMINÉ 

Cross border center for "studies of proteins for cancer" for research and diagnostics (PROTEO)

Date du début: 30 sept. 2012, Date de fin: 29 avr. 2015,

...the active cell duplication and as such are used as a biomarker for tumors. Better knowledge of biochemistry and structure of these proteins is one of the preconditions for the development of new anticancer drugs.
Voir le projet

 6

 TERMINÉ 

Cross-border biomarker research of ovarian cancer (CrossBiomark)

Date du début: 31 janv. 2013, Date de fin: 30 juil. 2014,

Ovarian cancer is the second most common malignant gynecological cancer estimated number of newly diagnosed patients is about 42700 in the European Union, while this number is 1300 in Hungary and 811 in Serbia per year. Unfortunately, 70 percent of patients has been diagnosed in advanced stage the disease by presently used CA-125 biomarker, when the cancer is spread throughout the abdomen and cau ...
Voir le projet

 2

 TERMINÉ 

Supplying lung adenocarcinoma cell lines to the cancer research community. (SLACC)

Date du début: 1 nov. 2015, Date de fin: 31 oct. 2016,

This project aims to protect, and commercialize a new panel of transplantable mouse lung cancer cell lines with defined mutation status (MLC) for cancer research and drug discovery. In addition, we aim at disseminating and exploiting a novel method for generating an unlimited pool of such lines from various strains of mice. Human lung cancer is characterized by a variety of mutations in oncogenes ...
Voir le projet

 1

 TERMINÉ 

Toward enhancing activities of European institutions in the FDUSCC-IM cancer research joint institute in China (IMMUNOCAN)

Date du début: 1 janv. 2012, Date de fin: 31 déc. 2015,

"The joint institute Fudan University Shanghai Cancer Centre – Institut Mérieux laboratory (FDUSCC-IM), created in May 2010, is conducting ambitious scientific research projects on oncology in China. Its 2 founding partners, Fudan University (China) and Transgene (part of Institut Mérieux, France) wish to increase their translational medical research cooperation with European countries. In a firs ...
Voir le projet

 5

 TERMINÉ 

Forefront Research in 3D Disease Cancer Models as in vitro Screening Technologies (FoReCaST)

Date du début: 1 juil. 2015, Date de fin: 30 juin 2020,

...etc). FoReCaST will attract to the Northern Portuguese region and UMINHO experienced human resources (ERA Chairs team) to settle in the region and to contribute to 5 strategic Research Lines (RLs) in cancer research field. The hiring of dedicated research staff will allow the nucleation of new strategic RLs, while simultaneously promoting the consolidation of pre-existing know-how by reinforcing s ...
Voir le projet

 1

 TERMINÉ 

Integrated Cross-Border Research Platform to Identify Cellular Processes as Potential Targets for Personalized Cancer Therapies (HUcanceRO)

Date du début: 31 déc. 2012, Date de fin: 30 déc. 2014,

The project aims at strengthening cross-border co-operation in the field of cancer research. Some specific objectives are the development of common new research infrastructure platform, cross-border research project on new approaches to cancer, cross-border educational project for advanced training on new in vitro and in vivo imaging techniques. The cross-border impact of the project is developing ...
Voir le projet

 3

 TERMINÉ 

Research Training in 3D Digital Imaging for Cancer Radiation Therapy (ENTERVISION)

Date du début: 1 févr. 2011, Date de fin: 31 janv. 2015,

The vision on a future high-precision radiation therapy utilizing either particle or photon beams is a treatment on a technological level which allows for: (1) obtaining information on relevant tumour parameters (volume, position, topology, density - also of the surrounding tissue) during every moment of therapeutic irradiation; (2) adapting the treatment plan in real time; and (3) initiating the ...
Voir le projet

 12

 TERMINÉ 

Interdisciplinary Cancer Research (INDICAR)

Date du début: 1 déc. 2013, Date de fin: 30 nov. 2018,

...t of academia and society at large, the University of Vienna will launch an initiative, the INDICAR Postdoctoral Fellowship Programme, to promote a new vision of postdoctoral training in the field of cancer research. Moreover the Programme will combine fundamental and application-oriented research, rendering the University and thus Europe, highly attractive for the sharpest minds. The INDICAR Prog ...
Voir le projet

 1

 TERMINÉ 

ERA-NET: Aligning national/regional translational cancer research programmes and activities (TRANSCAN-2)

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2019,

Cancer is a worldwide health burden and represents a major public health challenge in Europe. It is responsible for 25% of all deaths, being the second most common cause of death after cardio-vascular diseases and the main cause of mortality among people aged 45–64. Today, an estimated 9 million individuals in Europe live with cancer (Globocan 2008, http://globocan.iarc.fr/). Cancer became a chron ...
Voir le projet

 30

 TERMINÉ 

Oxford Innovative Organic Synthesis in Cancer Research Doctoral Programme (OxIOSCR)

Date du début: 1 mars 2013, Date de fin: 28 févr. 2017,

The Oxford Innovative Organic Synthesis for Cancer Research IDP (OxIOSCR) will seed a revolution in the practice of organic synthesis, by training graduate synthetic chemists for the first time to integrate seamlessly chemical, biocatalytic, and reagentless organic synthesis techniques with the latest advances in reaction technology. The synthetic chemistry will be shaped by a focus on target comp ...
Voir le projet

 1

 TERMINÉ 

Three dimensional breast cancer models for X-ray Imaging research (MaXIMA)

Date du début: 1 janv. 2016, Date de fin: 31 déc. 2018,

...bility of such models is a powerful instrument in the hands of engineers, physicians and physicists to be used in the development of new technologies for precise definition of the boundaries of these cancers. Scientists from the biomedical engineering unit at Technical University of Varna are present in this area both at modelling and simulation of computational breast phantoms and x-ray breast im ...
Voir le projet

 3

 TERMINÉ 

Natural Killer Cell-Based Anti-Cancer Immunotherapies: Research training in molecular medicine and biotechnology business (NATURIMMUN)

Date du début: 1 oct. 2012, Date de fin: 30 sept. 2016,

...ies of NK/T cells. It will further undertake basic studies on the potential of the newly emerging iPS cell technology for reconstituting immune systems including NK cells in patients with hematologic cancers.All students of this ITN will be trained in state-of-the-art immunotechnology including wider aspects of molecular medicine at the individual partner universities. An exchange of students betw ...
Voir le projet

 12

 TERMINÉ 

The Chernobyl Tissue Bank – Coordinating International Research on Radiation Induced Thyroid Cancer (CTB)

Date du début: 1 mai 2008, Date de fin: 31 déc. 2012,

This proposal is for continued support for a high quality tissue bank of clinically and pathologically annotated biological samples from patients who have developed thyroid tumours following exposure to radiation from the Chernobyl nuclear accident. It not only provides biological material to researchers world-wide but will collate research data from all projects using the resource in a web-access ...
Voir le projet

 5

 TERMINÉ 

A European Collaboration to optimise research for the care of cancer patients in the last days of life (OPCARE9)

Date du début: 1 mars 2008, Date de fin: 31 mars 2011,

...re to be delivered in the last days of life and gaps in the knowledge base. In addition, it aims to develop innovative ways of addressing gaps in knowledge with the specific aim of improving care for cancer patients in the last days of life. Clearly, such improvements would also impact positively on their informal carers and health professionals delivering the care. Importantly, it aims to do this ...
Voir le projet

 9

 TERMINÉ 

DIsseminate Research funded by EC improving Treatment options for children suffering from cancer (DIRECT)

Date du début: 1 mars 2008, Date de fin: 31 oct. 2010,

...ery. While publicly funded research is increasingly openly accessible, complex individual findings require a more global approach to make their societal benefits tangible. “Children suffering from cancer” is a highly emotional issue which catches the attention of those not directly concerned. Moreover, research from public funds, including the Framework Programmes has contributed to the substanti ...
Voir le projet

 4

 TERMINÉ 

Europe against Cancer: Optimisation of the Use of Registries for Scientific Excellence in research (EUROCOURSE)

Date du début: 1 avr. 2009, Date de fin: 30 sept. 2012,

"EUROCOURSE will tackle fragmentation in the funding and usage of cancer registries in Europe. It will do so by exploring ways to link and integrate national/regional programmes aimed at supporting cancer registries and research carried out using registry data. At the same time EUROCOURSE is seeking to optimize the use of cancer registration data for the amelioration of cancer control and the stre ...
Voir le projet

 15

 TERMINÉ 

Development of cross-border cooperation in order to improve public health conditions of the bielski district and Luboml rayon through programs of health promotion and prevention in the field of oncological diseases and tuberculosis (IPBU.03.01.00-20-423/11)

Date du début: 28 févr. 2013, Date de fin: 27 févr. 2015,

...se to carry out preventive examinations and insufficient number of prevention programs in the field of oncological diseases and tuberculosis. This is why informational campaign for early detection of cancer and tuberculosis is planned together with purchase of medical equipment, introduction of latest medical technologies (diagnostic imaging ultrasound apparatus and mobile X-ray system as an examp ...
Voir le projet

 2

 TERMINÉ 

Novel organometallic anticancer compounds (Organomet)

Date du début: 1 janv. 2013, Date de fin: 30 avr. 2014,

Currently the most widely used drugs for the treatment of cancer are platinum compounds, used in nearly 50% of all chemotherapeutic regimens. However the platinums can suffer from problems of resistance, a limited spectrum of activity, and side-effects. Hence new agents with new mechanisms of action are urgently needed. We have discovered novel organometallic osmium and iridium compounds with mor ...
Voir le projet

 1

 TERMINÉ 

p73 dependence in cancer: from molecular mechanisms to therapeutic targeting (P73CANCER)

Date du début: 1 oct. 2010, Date de fin: 30 sept. 2016,

"p73 is a transcription factor of the p53 tumor suppressor family. In approximately 50% of all cancer patientsthe tumor suppressor function of p53 is irreversibly disabled by point mutations, which makes p53 one of themost frequently mutated genes in cancer. This is entirely different for p73 and much of my previous work inthis field has been devoted to research on the role of p73 in cancer.In sha ...
Voir le projet

 1

 TERMINÉ 

Radiation Response Models for Personalised Radiation Oncology (RadResPRO)

Date du début: 1 juin 2014, Date de fin: 31 mai 2017,

Clinical radiotherapy for cancer has seen dramatic improvements in recent years, driven by developments in imaging and delivery techniques. However, the ability to deliver radiation is now out-stripping radiotherapy planning techniques. Despite the goal of radiotherapy – tumour control – being primarily biological, radiotherapy planning tools focus on a purely physical metric: dose. This has signi ...
Voir le projet

 1

 TERMINÉ 

Nanocapsules for targeted delivery of radioactivity (RADDEL)

Date du début: 1 févr. 2012, Date de fin: 31 janv. 2016,

...e design, synthesis, characterisation, pharmacological studies and dosimetry calculations of nanocapsules that seal in their interior radioactive materials for biomedical applications in the areas of cancer diagnosis and therapy. After sealing the chosen radionuclides, the external walls of the nanocapsules will be decorated with biomolecules to render them biocompatible and for targeting purposes ...
Voir le projet

 10

 TERMINÉ 

Genetic and environmental risk factors for common malignant tumours especially breast cancer and melanoma (risk factors cancer)

Date du début: 1 avr. 2012, Date de fin: 31 mars 2017,

...r disease is that environmental and/or genetic risk factors are characterized in order to better define risk groups. The present research proposal focus on common malignant tumours, especially breast cancer and malignant melanoma . By combining risk factor studies on endogenous and exogenous environmental, and genetic risk factors and its interaction, the aim is to better characterize strong dete ...
Voir le projet

 1

 TERMINÉ 

A novel Androgen Synthesis Pathway in treatment-REsistant Prostate Cancer (ASPIRE-PC)

Date du début: 1 mars 2014, Date de fin: 31 juil. 2015,

Prostate cancer (PC) is the most prevalent non-cutaneous cancer in men and leads to high morbidity and mortality. Disseminated PC is treated by hormonal treatment in order to block intratumoral activation of the androgen receptor (AR) by 5α-dihydrotestosterone (DHT). Despite this treatment, eventually all patients develop castration-resistant disease (CRPC) which is accompanied by poor prognosis. ...
Voir le projet

 1

 TERMINÉ 

Development of mass spectrometric techniques for 3D imaging and in-vivo analysis of biological tissues (DESI_JeDI-Imaging)

Date du début: 1 sept. 2008, Date de fin: 31 août 2013,

...I-MS,similarly to water jet surgery, also utilizes high velocity water jet can directly be used as an intelligent scalpel. Real-time in-situ tissue identification has the potential of revolutionizing cancer surgery, since this way the amount of removed tissue can be minimized, while the tumor removal efficiency is maximized. The identical experimental platform can also be used to gather real-time ...
Voir le projet

 3

 TERMINÉ 

High Throughput Proteomics Systems for Accelerated Profiling of Putative Plasma Biomarkers (PROACTIVE)

Date du début: 1 oct. 2008, Date de fin: 30 sept. 2011,

...tium combines three SMEs across Europe with synergistic competences in technology development, reagent manufacturing, and software development for data management and analysis. Together with clinical cancer scientists, biostatisticians, and diagnostics industry, these high capacity tools will be evaluated in pilot projects for cancer biomarkers using biobanked samples. Preliminary data in the lit ...
Voir le projet

 6

 TERMINÉ 

Secretariat for the International Consortium for Personalised Medicine (IC PerMed) (ICPerMed Secretariat)

Date du début: 1 nov. 2016, Date de fin: 31 oct. 2020,

...by taking into account individuals' genotypes and phenotypes as well as other biomedical, life style and environmental data. In the last decade, significant advancements have been made especially for cancer or rare diseases. However, due to fragmentation and high upfront-investments the implementation of PM remains challenging, besides the various ongoing research and implementation actions on Eur ...
Voir le projet

 4